Which ETFs hold Abbott Laboratories (ABT)?
Makes medical devices, diagnostic tests, nutrition products and generic medicines.
31 Australian ETFs hold Abbott Laboratories, a Health Care company from United States. DRUG has the biggest weighting at 2.53%. Across these funds, Australian ETF investors own about $235m of Abbott Laboratories.
The ETFs with the most Abbott Laboratories
All 31 ETFs that hold Abbott Laboratories, ranked by weight
Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.
Weights from each issuer's published holdings (September to November 2026). Some funds list only their largest holdings. General information only, not a recommendation to buy or sell Abbott Laboratories.
Common questions
Which ETF has the most Abbott Laboratories?
DRUG (Betashares Global Healthcare Currency Hedged ETF) has the highest weighting, with 2.53% of the fund in Abbott Laboratories.
What is the cheapest ETF that holds Abbott Laboratories?
Of the ETFs where Abbott Laboratories is at least 1% of the fund, IXJ has the lowest fee at 0.41% a year, with 2.07% in Abbott Laboratories.
How much Abbott Laboratories do I own with $10,000 in VGS?
About $19. VGS is the largest ETF that holds Abbott Laboratories, and Abbott Laboratories makes up 0.19% of it.
How many Australian ETFs hold Abbott Laboratories?
31 ETFs listed on the ASX or TMX Australia hold Abbott Laboratories, based on issuers' published holdings.